Singapore led Southeast Asia in healthtech and life sciences funding in 2024, raising $92.4m across 14 rounds, Traxcn reported.

Genting Sing is the most active stock, followed by Sembcorp Ind (2.76%) and YZJ Shipbldg SGD (+2.69%). Wilmar Intl and DFIRG USD were at the foot.

Singtel unit, Optus Finance, has signed a $1.64b (A$1.95b) committed revolving credit facility with 12 banks in Australia.

GuocoLand has sold Lentor Modern, the sole integrated mixed-use development in the Lentor Hills estate, after a complete sell ...

Singapore Airlines ranked 28th on Fortune’s 2025 World’s Most Admired Companies list. SIA was also the highest-ranked airline ...

Seatrium was awarded the contract to construct a 5,000-tonne fully revolving heavy lift vessel for the Japanese offshore wind ...

AHPs, pharmacists, and administrative, ancillary, and support staff in public healthcare will receive salary increases by mid ...

The Singapore data center market is projected to expand significantly, growing from US$1.3b in 2023 to US$3b by 2032, ...

Giving businesses the flexibility for recruiting international talent will help accelerate their operations within the ...

The National University of Singapore (NUS) will establish Acacia College, its fifth Residential College (RC) in University ...

Trip.com’s CEO, Jane Sun said that Southeast Asia will be the company’s top travel destination for 2025 and beyond.